Treatment of patients with allergic conjunctivitis: experience of an outpatient ophthalmologist
DOI: 10.32364/2311-7729-2025-25-1-8
G.A. Azamatova1, G.R. Altynbaeva2
1Bashkir State Medical University, Ufa, Russian Federation
2City Clinical Hospital No. 5 of the city of Ufa, Ufa, Russian Federation
Allergic conjunctivitis (AC) is one of the common eye diseases. To treat it, several groups of medications such as antihistamines, membrane stabilizers, vasoconstrictors, corticosteroids, non-steroidal anti-inflammatory drugs, reparative agents, keratoprotective products, tear supplements, immunotropic and antiseptic drugs, etc. are used. In ophthalmological practice, one of the vital issues is to choose the best possible drug for rapid and efficient relief of allergic conjunctivitis.
The paper reports a therapeutic approach involving epinastine 0.05%, an antihistamine with a dual mechanism of action, to treat seasonal AC. The observation included 30 subjects (24 females, 6 males) aged 19 — 56 years who consulted an ophthalmologist with various manifestations of seasonal AC, and the drug was added to the therapy regimen. Besides, the paper details clinical cases demonstrating diversity of allergic conjunctivitis in the practice of an outpatient ophthalmologist. The clinical efficacy of epinastine 0.05% was proven to relieve signs and symptoms of seasonal allergic conjunctivitis in the subjects. They reported good tolerability, as well as absence of unpleasant sensations and discomfort including those associated with ocular surface alterations (i.e., "dry eye" syndrome).
Keywords: allergic conjunctivitis, seasonal conjunctivitis, pollinous conjunctivitis, conjunctivitis treatment, epinastine.
For citation: Azamatova G.A., Altynbaeva G.R. Treatment of patients with allergic conjunctivitis: experience of an outpatient ophthalmologist. Russian Journal of Clinical Ophthalmology. 2025;25(1):54–59 (in Russ.). DOI: 10.32364/2311-7729-2025-25-1-8
About the authors:
Gulnara A. Azamatova — C. Sc. (Med.), Assistant Professor, Assistant Professor of the Department of Ophthalmology, Bashkir State Medical University; 3, Lenin str., Ufa, 450008, Russian Federation; ORCID iD 0000-0001-8158-8333
Gulnaz R. Altynbaeva — C. Sc. (Med.), Ophthalmologist, Outpatient Department no. 3, City Clinical Hospital No. 5 of the city of Ufa; 93, Parkhomenko str., Ufa, 450005, Russian Federation; ORCID iD 0000-0002-0870-4630
Contact information: Gulnara A. Azamatova, e-mail: azamatova_g@mail.ru
Financial Disclosure: the authors have no a financial or property interest in any material or method mentioned.
There is no conflict of interest.
Received 16.12.2024.
Revised 12.01.2025.
Accepted 30.01.2025.
2. Нероев В.В., Вахова Е.С. Аллергические конъюнктивиты. В кн.: Офтальмология: Национальное руководство. Под ред. С.Э. Аветисова, Е.А. Егорова, Л.К. Мошетовой и др. 2-е изд., перераб. и доп. М.: ГЭОТАР-Медиа; 2018.Neroev V.V., Vahova E.S. Allergic conjunctivitis. In: Ophthalmology: National Guidelines. Avetisov S.E., Egorov E.A., Moshetova L.K. et al. 2nd ed., revised and enlarged. M.: GEOTAR-Media; 2018 (in Russ.).
3. Dupuis P., Prokopich C., Hynes A. et al. A contemporary look at allergic conjunctivitis. Allergy Asthma Clin Immunol. 2020;16:5. DOI: 10.1186/s13223-020-0403-9
4. Leonardi A., Castegnaro A., Valerio A.L. et al. Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study. Curr Opin Allergy Clin Immunol. 2015;15(5):482–488. DOI: 10.1097/ACI.0000000000000204
5. Miyazaki D., Fukagawa K., Okamoto S. et al. Epidemiological aspects of allergic conjunctivitis. Allergol Int. 2020;69(4):487–495. DOI: 10.1016/j.alit.2020.06.004
6. Аллергический ринит и аллергический конъюнктивит у детей: от теории к практике. Эффективная фармакотерапия. 2024;20(17):34–40.Allergic Rhinitis and Allergic Conjunctivitis in Children: from Theory to Practice. Effective Pharmacotherapy. 2024;20(17):34–40 (in Russ.).
7. Miyazaki D., Fukagawa K., Fukushima A. et al. Air pollution significantly associated with severe ocular allergic inflammatory diseases. Sci Rep. 2019;9:18205. DOI: 10.1038/s41598-019-54841-4
8. Егоров А.Е., Захарова М.А. Лечение пациента с аллергическим конъюнктивитом: рекомендации офтальмологу амбулаторного звена. РМЖ. Клиническая офтальмология. 2017;2:111–114.Egorov A.E., Zakharova М.A. Treatment of a patient with allergic conjunctivitis: recommendations to the outpatient ophthalmologist. RMJ. Clinical ophthalmology. 2017;2:111–114 (in Russ.).
9. Княжеская Н.П., Фабрика М.П. Сезонные проявления аллергии: некоторые подходы к лечению сезонного аллергического ринита и сезонного аллергического конъюнктивита. Фарматека. 2012;5(238):20–25.Knyazheskaya N.P., Fabrika M.P. Seasonal Manifestations Of Allergy: Some Approaches To The Treatment Of Seasonal Allergic Rhinitis And Seasonal Allergic Conjunctivitis. Farmateka. 2012;5(238):20–25 (in Russ.).
10. Нероев В.В., Вахова Е.С. Заболевания конъюнктивы. Национальное руководство по офтальмологии. М.: ГЭОТАР-Медиа; 2017.Neroev V.V., Vakhova E.S. Diseases of the conjunctiva. National Guide for Ophthalmology. М.: GEOTAR-Media; 2017 (in Russ.).
11. Ковалевская М.А., Майчук Д.Ю., Бржеский В.В. Синдром «красного глаза»: Практическое руководство для врачей-офтальмологов. М.; 2010.Kovalevskaya M.A., Maychuk D.Yu., Brzhesky V.V. "Red eye" syndrome. A practical guide for ophthalmologists. M.; 2010 (in Russ.).
12. Яни Е.В., Позднякова В.В., Селиверстова К.Е. Новые возможности терапии лекарственных офтальмоаллергозов. Российский офтальмологический журнал. 2017;10(3):108–112.Jani E.V., Pozdnyakova V.V., Seliverstova K.E. New opportunities of the therapy of medicinal ophthalmic allergies. Russian Ophthalmological Journal. 2017;10(3):108–112 (in Russ.). DOI: 10.21516/2072-0076-2017-10-3-108-112
13. Яни Е.В. Применение нового противоаллергического препарата Эпинепта® в терапии сезонного аллергического конъюнктивита. Клинические случаи. Российский офтальмологический журнал. 2023;16(4):141–146. DOI: 10.21516/2072-0076-2023-16-4-141-146Yani E.V. Using a new antiallergic drug Epinepta® in the treatment of seasonal allergic conjunctivitis. Clinical cases. Russian ophthalmological journal. 2023;16(4):141–146 (in Russ.). DOI: 10.21516/2072-0076-2023-16-4-141-146
14. Brubaker K., Yerxa B.R. In vitro Analysis of the Antagonism of the Histamine H1 Receptor by Epinastine: A Kinetic Comparison With Other Marketed Compounds. Invest Ophthalmol Vis Sci. 2006;47(13):4975.
15. Pradhan S., Abhishek K., Mah F. Epinastine: Topical ophthalmic second generation antihistamine without significant systemic side effects. Expert Opin Drug Metab Toxicol. 2009;5(9):1135–1140. DOI: 10.1517/17425250903117284
16. Bielory L., Lien K.W., Bigelsen S. Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis. Drugs. 2005;65(2):215–228. DOI: 10.2165/00003495-200565020-00004
17. Wolf S.C., Brubaker K., Navrátil Т. Evaluation of muscarinic receptors antagonism by antihistamines. Allergy. 2007;62:138.
18. Abelson M.B., Gomes P., Crampton H.J. et al. Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis. Clin Ther. 2004;26(1):35–47. DOI: 10.1016/s0149-2918(04)90004-5
19. Майчук Д.Ю., Чилингарян Л.Б., Пронкин И.А. и др. Слезозаместительная терапия при аллергических состояниях глаз. Офтальмология. 2012;9(2):72–76. DOI: 10.18008/1816‑5095‑2012‑2‑72‑76Maychuk D.Yu., Chilingaryan L.B., Pronkin I.A. et al. Use of artificial tears in cases of allergic conjunctivitis. Ophthalmology in Russia. 2012;9(2):72–76 (in Russ.). DOI: 10.18008/1816‑5095‑2012‑2‑72‑76
20. Villareal A.L., Farley W., Pflugfelder S.C. Effect of topical ophthalmic epinastine and olopatadine on tear volume in mice. Eye Contact Lens. 2006;32(6):272–276. DOI: 10.1097/01.icl.0000224360.10319.b1
This work is licensed under a Creative Commons «Attribution» 4.0 License.
